Core Viewpoint - Johnson Fistel, PLLP is investigating RXO, Inc. for potential violations of federal securities laws related to misrepresentation or failure to disclose material information to investors [1]. Group 1: Investigation Details - The investigation focuses on whether RXO, Inc. or its officers and directors misrepresented or failed to timely disclose material information to investors [1]. - Investors who purchased RXO securities and suffered losses are encouraged to join the investigation [2]. Group 2: About Johnson Fistel, PLLP - Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices across multiple states, representing both individual and institutional investors in securities class action lawsuits [3]. - The firm has been recognized as a top plaintiffs' securities law firm, having recovered approximately $90.725 million for clients in cases where it served as lead or co-lead counsel [4].

Core Viewpoint - Kaskela Law LLC is investigating MediaAlpha, Inc. on behalf of long-term investors due to a significant decline in the company's stock price and potential violations of securities laws or fiduciary duties by the company's officers and directors [1][3]. Stock Performance - Since February 2024, MediaAlpha's stock has decreased from over $21.00 per share to less than $12.00 per share, representing a cumulative decline of over $9.00 per share, or over 42% in value [2]. Legal Investigation - The investigation aims to determine if MediaAlpha and its executives breached securities laws or fiduciary duties in relation to recent corporate actions [3]. Investor Communication - Current shareholders of MediaAlpha are encouraged to contact Kaskela Law LLC for more information regarding the investigation and their legal rights [4]. Firm Background - Kaskela Law LLC has a history of representing investors in securities fraud and corporate governance cases, having recovered over $500 million for investors since 2020 [4].

Group 1 - Pomerantz LLP is investigating claims on behalf of investors of NuScale Power Corporation regarding potential securities fraud or unlawful business practices by the company and its officers/directors [1] - Citigroup downgraded NuScale from Neutral/High Risk to Sell/High Risk on October 21, 2025, citing competition from new entrants and the lack of a binding customer contract [2] - Following the downgrade, NuScale's stock price fell by $9.49 per share, or 21.47%, closing at $34.72 per share on October 22, 2025 [3]

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving Alector, Inc. following disappointing clinical trial results for its drug, latozinemab, which did not meet primary endpoints [1][2]. Group 1: Company Overview - Alector, Inc. is a biotechnology company focused on developing therapies for neurodegenerative diseases [2]. - The company recently announced results from the Phase 3 INFRONT-3 clinical trial for latozinemab, which targets frontotemporal dementia due to a progranulin gene mutation [2]. Group 2: Clinical Trial Results - The Phase 3 clinical trial results indicated that latozinemab failed to meet its clinical co-primary endpoint of slowing the progression of frontotemporal dementia [2]. - Secondary and exploratory endpoints, including fluid biomarkers and volumetric magnetic resonance imaging (vMRI), showed no treatment-related effects [2]. Group 3: Market Reaction - Following the announcement of the trial results, Alector's stock price dropped by $1.60 per share, representing a decline of 49.84%, closing at $1.61 per share on October 22, 2025 [2].

Core Viewpoint - A class action securities lawsuit has been filed against WPP plc, alleging securities fraud that negatively impacted investors between February 27, 2025, and July 8, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that WPP's management provided overly positive statements while concealing material adverse facts about the company's media arm, which was struggling to cope with macroeconomic challenges and losing market share [2]. - On July 9, 2025, WPP reported a deterioration in performance for Q2 2025, attributing this to macroeconomic uncertainty and weaker new business, partly due to ongoing restructuring within WPP Media (GroupM) [2]. - Following the trading update, WPP's stock price plummeted from $35.82 per share on July 8, 2025, to $29.34 per share on July 9, 2025, marking an 18.1% decline in a single day [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified period have until December 8, 2025, to request appointment as lead plaintiff in the lawsuit [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

Core Points - A securities fraud class action lawsuit has been filed against WPP plc, alleging violations of the Securities Exchange Act of 1934 [2] - The lawsuit claims that WPP misrepresented its media arm's capabilities to handle macroeconomic challenges [2] - Investors who purchased WPP common stock between February 27, 2025, and July 8, 2025, are eligible to participate in the lawsuit [2][3] Legal Proceedings - The deadline to file as a lead plaintiff in the class action is December 8, 2025 [3] - Representation in the lawsuit is on a contingency fee basis, meaning shareholders incur no fees or expenses [3] - Investors can remain absent class members if they choose not to take action [3] Firm Background - Bernstein Liebhard LLP has recovered over $3.5 billion for clients since 1993 and has a strong track record in class action litigation [4] - The firm has been recognized multiple times in The National Law Journal's "Plaintiffs' Hot List" and has been listed in The Legal 500 for sixteen consecutive years [4]

Core Viewpoint - Molina Healthcare, Inc. is currently facing challenges including a class action lawsuit and a significant decline in stock price, which may affect investor confidence and market performance [3][4][5] Company Overview - Molina Healthcare provides managed healthcare services primarily to low-income individuals, operating in the Medicaid and Medicare sectors [1] - The company competes with other healthcare providers such as Centene Corporation and UnitedHealth Group [1] Stock Performance - The current stock price of Molina Healthcare is $165.42, reflecting a 2.74% increase with a $4.42 rise today [2] - Despite the recent increase, the stock has experienced a significant decline of 16% recently, raising concerns for investors [2][5] - The stock's 52-week range is between $151.95 and $359.97, indicating high volatility [2] Legal Issues - A class action lawsuit has been filed against Molina Healthcare, alleging securities fraud and other unlawful practices [3] - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., and is pending in the U.S. District Court for the Central District of California [4] - This legal challenge could impact investor confidence and the company's market performance [4] Market Capitalization and Trading Activity - Molina Healthcare's market capitalization is approximately $8.97 billion [4] - The trading volume is 715,671 shares, indicating active investor interest despite ongoing legal issues [4]

Core Points - A class action lawsuit has been filed against WPP Plc for potential securities fraud and unlawful business practices [2] - Investors who purchased WPP securities during the Class Period have until December 8, 2025, to apply as Lead Plaintiff [2] - WPP reported a deterioration in performance for Q2 2025, attributing it to macroeconomic uncertainty and weaker new business [4] - Following the trading update, WPP's ADR price fell by $6.48, or 18.09%, closing at $29.34 [5] Company Overview - WPP Plc is facing legal scrutiny due to allegations of securities fraud and misconduct by its officers and directors [2] - The company has been undergoing restructuring, which has reportedly distracted from its business performance [4] - Pomerantz LLP, the firm handling the class action, is recognized for its expertise in corporate and securities class litigation [6]

Core Viewpoint - A class action securities lawsuit has been filed against RCI Hospitality Holdings, Inc. alleging securities fraud that affected investors between December 15, 2021, and September 16, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that the defendants engaged in tax fraud and bribery to conceal this fraud, leading to an understatement of the legal risks facing the company [3]. - It is alleged that the defendants' statements regarding the company's business, operations, and prospects were materially false and misleading [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until November 20, 2025, to request to be appointed as lead plaintiff, although participation does not require this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [5].

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lantheus investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/lantheus-holdings ...